Fifth Third Bancorp Novartis Ag Transaction History

Fifth Third Bancorp

  • $27.3 Billion
  • Q3 2024

A detailed history of Fifth Third Bancorp transactions in Novartis Ag stock. As of the latest transaction made, Fifth Third Bancorp holds 47,301 shares of NVS stock, worth $4.69 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
47,301
Previous 47,066 0.5%
Holding current value
$4.69 Million
Previous $5.01 Million 8.58%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
BUY
$106.13 - $120.89 $24,940 - $28,409
235 Added 0.5%
47,301 $5.44 Million
Q2 2024

Jul 22, 2024
SELL
$92.57 - $107.37 $1.26 Million - $1.46 Million
-13,559 Reduced 22.37%
47,066 $5.01 Million
Q1 2024

Apr 23, 2024
BUY
$95.27 - $108.47 $141,952 - $161,620
1,490 Added 2.52%
60,625 $5.86 Million
Q4 2023

Jan 19, 2024
SELL
$92.27 - $101.54 $172,637 - $189,981
-1,871 Reduced 3.07%
59,135 $5.97 Million
Q3 2023

Oct 31, 2023
SELL
$94.73 - $105.13 $28,892 - $32,064
-305 Reduced 0.5%
61,006 $6.21 Million
Q2 2023

Jul 25, 2023
SELL
$92.52 - $104.91 $464,913 - $527,172
-5,025 Reduced 7.58%
61,311 $6.19 Million
Q1 2023

Apr 24, 2023
SELL
$80.03 - $92.81 $84,671 - $98,192
-1,058 Reduced 1.57%
66,336 $6.1 Million
Q4 2022

Jan 25, 2023
BUY
$75.55 - $92.52 $10,048 - $12,305
133 Added 0.2%
67,394 $0
Q3 2022

Oct 25, 2022
SELL
$74.61 - $87.26 $498,320 - $582,809
-6,679 Reduced 9.03%
67,261 $5.11 Million
Q2 2022

Aug 04, 2022
SELL
$80.52 - $93.75 $286,168 - $333,187
-3,554 Reduced 4.59%
73,940 $6.25 Million
Q1 2022

Apr 19, 2022
SELL
$80.11 - $90.62 $63,046 - $71,317
-787 Reduced 1.01%
77,494 $6.8 Million
Q4 2021

Feb 01, 2022
SELL
$79.7 - $88.13 $87,988 - $97,295
-1,104 Reduced 1.39%
78,281 $6.85 Million
Q3 2021

Oct 15, 2021
SELL
$81.78 - $95.14 $286,148 - $332,894
-3,499 Reduced 4.22%
79,385 $6.49 Million
Q2 2021

Aug 06, 2021
SELL
$85.24 - $94.15 $348,546 - $384,979
-4,089 Reduced 4.7%
82,884 $7.56 Million
Q1 2021

May 07, 2021
SELL
$83.5 - $98.47 $130,093 - $153,416
-1,558 Reduced 1.76%
86,973 $7.43 Million
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $24,748 - $29,934
-317 Reduced 0.36%
88,531 $8.36 Million
Q3 2020

Nov 09, 2020
SELL
$82.14 - $91.0 $70,804 - $78,442
-862 Reduced 0.96%
88,848 $7.73 Million
Q2 2020

Aug 05, 2020
BUY
$80.93 - $91.1 $3,399 - $3,826
42 Added 0.05%
89,710 $7.84 Million
Q1 2020

May 05, 2020
SELL
$70.67 - $99.01 $8,692 - $12,178
-123 Reduced 0.14%
89,668 $7.39 Million
Q4 2019

Feb 14, 2020
SELL
$84.35 - $95.37 $42,765 - $48,352
-507 Reduced 0.56%
89,791 $8.5 Million
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $302,554 - $333,397
-3,537 Reduced 3.77%
90,298 $7.85 Million
Q2 2019

Aug 07, 2019
SELL
$75.4 - $92.8 $491,306 - $604,684
-6,516 Reduced 6.49%
93,835 $8.57 Million
Q1 2019

May 14, 2019
SELL
$75.32 - $86.15 $164,348 - $187,979
-2,182 Reduced 2.13%
100,351 $9.65 Million
Q4 2018

Feb 14, 2019
SELL
$73.66 - $82.02 $375,518 - $418,137
-5,098 Reduced 4.74%
102,533 $8.8 Million
Q3 2018

Nov 14, 2018
SELL
$66.94 - $77.43 $1.27 Million - $1.47 Million
-19,037 Reduced 15.03%
107,631 $9.27 Million
Q2 2018

Aug 14, 2018
SELL
$64.91 - $73.36 $4.01 Million - $4.53 Million
-61,732 Reduced 32.77%
126,668 $9.57 Million
Q1 2018

May 15, 2018
SELL
$70.39 - $84.15 $481,960 - $576,175
-6,847 Reduced 3.51%
188,400 $15.2 Million
Q4 2017

Feb 14, 2018
SELL
$72.33 - $77.64 $328,450 - $352,563
-4,541 Reduced 2.27%
195,247 $16.4 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $1.16 Million - $1.21 Million
15,598 Added 8.47%
199,788 $17.2 Million
Q2 2017

Aug 11, 2017
BUY
N/A
184,190
184,190 $15.4 Million

Others Institutions Holding NVS

# of Institutions
1,438
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email